Widely used:Recently Viewed
Clear All$29.02
$2.65
(10.04%)
As on 23-Jun-2025 13:33EDT
Today’s Range
52 Week Range
Liquidity
Market cap
$701 Mln
Revenue (TTM)
$315 Mln
Net Profit (TTM)
$-169 Mln
ROE
0.4 %
ROCE
-- %
P/E Ratio
1328.5
P/B Ratio
419.4
Industry P/E
--
EV/EBITDA
773.1
Div. Yield
0 %
Debt to Equity
0
Book Value
$0
EPS
$0
Face value
--
Shares outstanding
26,374,400
CFO
$--
EBITDA
$--
Net Profit
$--
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
| 360.8 | 103.9 | 130.2 | -- | -- | -- | -- |
|
BSE Sensex
| 4.7 | 1.2 | 6.5 | 6.1 | 16.5 | 18.6 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH)
|
29.0 | 700.8 | 2.4 | 0.5 | -57.1 | 38 | 1328.5 | 419.4 |
| 45.5 | 10,955.3 | 5,304.0 | -630.0 | -4.7 | -- | -- | 1.2 |
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic... skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd. Read more
CEO & Chairman of the Board
Ms. Xiaoqiu Zhang
CEO & Chairman of the Board
Ms. Xiaoqiu Zhang
Headquarters
Wuxi
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH) stood at $ 3 Mln as on 31-Dec-24
The share price of Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH) is $29.02 (NASDAQ) as of 23-Jun-2025 13:33 EDT. Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH) has given a return of --% in the last 1 years.
Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH) has a market capitalisation of $ 701 Mln as on 20-Jun-2025. As per Value Research classification, it is a Small Cap company.
Since, TTM earnings of Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH) is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH) and enter the required number of quantities and click on buy to purchase the shares of Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH).
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People's Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees. The company was founded in 2016 and is headquartered in Wuxi, the People's Republic of China. Park Ha Biological Technology Co., Ltd. operates as a subsidiary of Xiaoqiu Holding Ltd.
The CEO & director of Ms. Xiaoqiu Zhang. is Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH), and CFO & Sr. VP is Ms. Xiaoqiu Zhang.
There is no promoter pledging in Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,096
|
| Park Ha Biological Technology Co., Ltd. Ordinary Shares (PHH) | Ratios |
|---|---|
|
Return on equity(%)
|
38
|
|
Operating margin(%)
|
33.32
|
|
Net Margin(%)
|
20.09
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Park Ha Biological Technology Co, Ltd Ordinary Shares (PHH) was $-169 Mln.
